Clinical trial data recorded headache as the most frequent adverse event, occurring in a small percentage of participants
requires screening and monitoring Tirzepatide (GLP-1/GIP medication) What it is: Prescription GLP-1/GIP medication Primary effect: Appetite regulation and satiety Evidence for weight loss: Strong What to know: FDA-approved options exist for chronic weight management
The PRMR Hospital Recommendation Group met on January 15 and 16, 2025 to review measures included by the Secretary on the publicly available 2024 Measures Under Consideration List (MUC List), including the Information Transfer PRO-PM, for potential use
Severe deficiency or neurological symptoms require injectable b12 for faster repletion
Vitamin B12 and Vitamin B1
These conditions have serious risks for both parents and fetuses, including preterm birth, fetal growth restriction, and an elevated risk of cardiovascular disease for mothers